Numerous studies have indicated dysregulation of kallikrein expression in various cancer types, which is associated with prognosis (Dorn et al., 2011; Hua et al., 2021; Lilja, Ulmert & Vickers, 2008; Obiezu et al., 2001; Zhu et al., 2018). Here, KLK4 is linked to cancer.